NCT03767972 is a NA clinical trial of Energy-based device in Rejuvenation, sponsored by University of California, Irvine.

Who is sponsoring NCT03767972?

NCT03767972 is sponsored by University of California, Irvine.

What drugs are being tested in NCT03767972?

Interventions in NCT03767972: Energy-based device.

What condition does NCT03767972 study?

NCT03767972 studies Rejuvenation.

Is NCT03767972 still recruiting?

NCT03767972 is currently terminated. Last updated 12 February 2026.

Are results published for NCT03767972?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2026-02-12 · How we verify

NCT03767972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Energy Devices for Rejuvenation

Terminated NA Results posted Last updated 12 February 2026

What this trial tests

NA trial testing Energy-based device in Rejuvenation in 24 participants. Terminated before completion.

Timeline

1 February 2018

Primary endpoint
17 September 2021

17 September 2021

Quick facts

Lead sponsor	University of California, Irvine
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	1 February 2018
Primary completion	17 September 2021
Estimated completion	17 September 2021
Sites	1 location across United States

Drugs / interventions tested

Energy-based device

Conditions studied

Rejuvenation — all drugs for Rejuvenation →

Sponsor

University of California, Irvine

Who can join

Adults 18 to 85, any sex, with Rejuvenation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Global Aesthetic Improvement Scale - Physician Primary · 3 months

Patients will be followed for post-treatment using a physician-reported 5-point likert scale (Global Aesthetic Improvement Scale) from 0="worse" to 4="very much improved".

Group	Value	95% CI
Rejuvenation	3	± 0

Global Aesthetic Improvement Scale - Patient Primary · 3 months

Patients will be followed for post-treatment using a patient-reported 5-point likert scale (Global Aesthetic Improvement Scale) from 0="worse" to 4="very much improved".

Group	Value	95% CI
Rejuvenation	3.5	± 0.58

Sponsor's own description

Non-ablative and ablative devices are the most commonly used minimally-invasive treatments for skin rejuvenation. Current devices on the market for rejuvenation include the lasers such as the Fraxel Restore, the Halo, the Helios III, the Pico, the ThermiVa and the DiVa which have all been shown to have efficacy for the rejuvenation of the face, décolletage, hands and vagina. In this study we propose to compare the efficacy and side effect profile of these devices for skin rejuvenation of various areas of the body including the face, décolletage, hands, trunk, upper and lower extremities, and vagina.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rejuvenation

Currently open trials in the same condition.

NCT07227883 — Secretome Treatment for Facial Rejuvenation · EARLY_PHASE1 · recruiting

Other University of California, Irvine trials

Trials by the same sponsor.

NCT06952725 — Chatbot for Online Support Groups to Treat Tobacco Addiction · NA · not yet recruiting
NCT07167862 — Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound · Phase 4 · not yet recruiting
NCT07527325 — Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma · Phase 2 · not yet recruiting
NCT07391891 — Musical Mindfulness for Pain in the ED Waiting Room · NA · not yet recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03767972 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Irvine
Last refreshed: 12 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing